Bortezomib with Dexamethasone in Newly Diagnosed Patients with Primary Systemic Light Chain Amyloidosis or Multiple Myeloma-Associated AL Amyloidosis

被引:1
|
作者
Huang, Beihui [1 ]
Li, Juan [1 ]
Liu, Junru [1 ]
Zheng, Dong [1 ]
Chen, Mei [1 ]
Zhou, Zhenhai [1 ]
Xu, Duorong [1 ]
Zou, Waiyi [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hematol, Guangzhou 510275, Guangdong, Peoples R China
关键词
D O I
10.1182/blood.V120.21.5036.5036
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
5036
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Multiple Myeloma-Associated Light Chain Amyloidosis and a Proposed Approach to Monoclonal Immunoglobulin-Associated Renal Disease
    Chang, Zi Yun
    Thamboo, Thomas Paulraj
    Choong, Clarice Shi Hui
    Wong, Weng Kin
    Ngoh, Clara Lee Ying
    CASE REPORTS IN NEPHROLOGY AND DIALYSIS, 2020, 10 (03): : 95 - 103
  • [42] The Coexistence of Multiple Myeloma-associated Amyloid Light-chain Amyloidosis and Fabry Disease in a Hemodialysis Patient
    Taguchi, Kensei
    Moriyama, Atsuo
    Kodama, Goh
    Nakayama, Yosuke
    Fukami, Kei
    INTERNAL MEDICINE, 2017, 56 (07) : 841 - 846
  • [43] Successful treatment of renal light chain (AL) amyloidosis with bortezomib and dexamethasone (VD)
    Huang, B.
    Li, J.
    Xu, X.
    Zheng, D.
    Zhou, Z.
    Liu, J.
    PATHOLOGIE BIOLOGIE, 2015, 63 (01): : 17 - 20
  • [44] Multiple myeloma-associated amyloidosis and giant cell arteritis
    Estrada, A
    Stenzel, TT
    Burchette, JL
    Allen, NB
    ARTHRITIS AND RHEUMATISM, 1998, 41 (07): : 1312 - 1317
  • [45] Herpesviral encephalitis associated with bortezomib use in a patient with multiple myeloma and associated light-chain amyloidosis
    Garrido, David
    Riva, Eloisa
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (07) : 1659 - 1663
  • [46] Primary Treatment of Light Chain (AL) Amyloidosis With Bortezomib, Lenalidomide and Dexamethasone (VRD) or with Bortezomib, Cyclophosphamide and Dexamethasone (VCD/CyBorD): efficacy and toxicity
    Kastritis, Efstathios
    Gavriatopoulou, Maria
    Fotiou, Despina
    Kanellias, Nikolaos
    Migkou, Magdalini
    Tselegkidi, Maria Irini
    Marinaki, Smaragdi
    Psimenou, Erasmia
    Ntanasis-Stathopoulos, Ioannis
    Gakiopoulou, Harikleia
    Papanota, Aristea-Maria
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10) : E320 - E321
  • [47] Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA
    Kenshi Suzuki
    Ashutosh D. Wechalekar
    Kihyun Kim
    Chihiro Shimazaki
    Jin Seok Kim
    Takayuki Ikezoe
    Chang-Ki Min
    Fude Zhou
    Zhen Cai
    Xiaonong Chen
    Shinsuke Iida
    Nagaaki Katoh
    Tomoaki Fujisaki
    Ho-Jin Shin
    NamPhuong Tran
    Xiang Qin
    Sandra Y. Vasey
    Brenda Tromp
    Brendan M. Weiss
    Raymond L. Comenzo
    Efstathios Kastritis
    Jin Lu
    Annals of Hematology, 2023, 102 : 863 - 876
  • [48] Myeloma Associated Primary Systemic Amyloidosis
    Kamal, Wan Syameen Afira Wan Ahmad
    Taib, Tarita
    Noor, Norizal Mohd
    Jong, Tan Jyh
    INDIAN JOURNAL OF DERMATOLOGY, 2016, 61 (01)
  • [49] Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA
    Suzuki, Kenshi
    Wechalekar, Ashutosh D. D.
    Kim, Kihyun
    Shimazaki, Chihiro
    Kim, Jin Seok
    Ikezoe, Takayuki
    Min, Chang-Ki
    Zhou, Fude
    Cai, Zhen
    Chen, Xiaonong
    Iida, Shinsuke
    Katoh, Nagaaki
    Fujisaki, Tomoaki
    Shin, Ho-Jin
    Tran, NamPhuong
    Qin, Xiang
    Vasey, Sandra Y. Y.
    Tromp, Brenda
    Weiss, Brendan M. M.
    Comenzo, Raymond L. L.
    Kastritis, Efstathios
    Lu, Jin
    ANNALS OF HEMATOLOGY, 2023, 102 (4) : 863 - 876
  • [50] Bortezomib Subcutaneous Injection in Combination Regimens for Myeloma or Systemic Light-Chain Amyloidosis: A Retrospective Chart Review of Response Rates and Toxicity in Newly Diagnosed Patients
    Shah, Gunjan
    Kaul, Esha
    Fallo, Shelly
    Cossor, Furha
    Smith, Hedy
    Sprague, Kellie
    Klein, Andreas
    Miller, Kenneth
    Comenzo, Raymond
    CLINICAL THERAPEUTICS, 2013, 35 (10) : 1614 - 1620